Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aceto Cp (ACET)

Aceto Cp (ACET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,148
  • Shares Outstanding, K 30,839
  • Annual Sales, $ 711,360 K
  • Annual Income, $ -316,120 K
  • 60-Month Beta 2.00
  • Price/Sales 0.01
  • Price/Cash Flow 0.13
  • Price/Book 0.08
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.06
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/02/19
  • Annual Dividend & Yield 0.02 (14.87%)
  • Most Recent Dividend 0.010 on 09/21/18
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.22
  • Growth Rate Est. (year over year) +453,990.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.13 +1.13%
on 04/02/19
0.30 -55.17%
on 03/12/19
-0.07 (-32.75%)
since 03/01/19
3-Month
0.13 +1.13%
on 04/02/19
1.82 -92.61%
on 02/08/19
-0.75 (-84.72%)
since 01/02/19
52-Week
0.13 +1.13%
on 04/02/19
7.58 -98.23%
on 04/18/18
-7.02 (-98.12%)
since 04/02/18

Most Recent Stories

More News
Delisting of Securities of Intellipharmaceutics International Inc., Aceto Corporation, and GTY Technology Holdings Inc. (Warrant only) from The Nasdaq Stock Market

The Nasdaq Stock Market announced today that it will delist the common stock of Intellipharmaceutics International Inc. Intellipharmaceutics International Inc.'s stock was suspended on March 21, 2019...

NDAQ : 96.87 (-1.44%)
ACET : 0.13 (-23.67%)
ACETO Completes the Sale of Its Chemicals Business Assets

ACETO Corporation (OTC: ACETQ) announced today that it has completed the previously disclosed sale of its chemicals business assets to an affiliate of New Mountain Capital, a leading growth-oriented investment...

ACETQ : 0.1508 (-7.20%)
ACET : 0.13 (-23.67%)
ACETO Completes the Sale of Rising Pharmaceuticals

ACETO Corporation (Nasdaq: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals,...

ACETQ : 0.1508 (-7.20%)
ACET : 0.13 (-23.67%)
New Mountain Capital Acquires ACETO Chemicals Business

New Mountain Capital, LLC, a leading growth-oriented investment firm with over $20 billion in assets under management, announced today that an affiliate has agreed to acquire the chemicals...

ACETQ : 0.1508 (-7.20%)
ACET : 0.13 (-23.67%)
ACETO to Sell its Chemicals Business Assets to New Mountain Capital

ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced...

ACETQ : 0.1508 (-7.20%)
ACET : 0.13 (-23.67%)
ACETO Receives Court Approval of "Stalking Horse" Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc.

ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced...

ACETQ : 0.1508 (-7.20%)
ACET : 0.13 (-23.67%)
ACETO Enters into "Stalking Horse" Agreement to Sell Rising Pharmaceuticals

ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced...

ACET : 0.13 (-23.67%)
Thinking about buying stock in Aceto, Canopy Growth Corp., Frontier Communications Corp., Midatech Pharma or Sea Ltd?

InvestorsObserver issues critical PriceWatch Alerts for ACET, CGC, FTR, MTP, and SE.

SE : 34.19 (-0.75%)
FTR : 1.43 (+2.88%)
MTP : 1.36 (-2.16%)
ACET : 0.13 (-23.67%)
ACETO Announces Receipt of Nasdaq Notice Due to Delay in Filing Form 10-Q for the Fiscal Quarter Ended December 31, 2018

ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced...

ACET : 0.13 (-23.67%)
ACETO Announces Proposed Sale of its Chemicals Business Assets to New Mountain Capital for $338 million

ACETO and its U.S. Subsidiaries File Voluntary Chapter 11 Petitions to Facilitate Sale

ACET : 0.13 (-23.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ACET with:

Business Summary

Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The company's operating segment consists of Human Health, Pharmaceutical Ingredients and...

See More

Key Turning Points

2nd Resistance Point 0.18
1st Resistance Point 0.16
Last Price 0.13
1st Support Level 0.12
2nd Support Level 0.11

See More

52-Week High 7.58
Fibonacci 61.8% 4.74
Fibonacci 50% 3.86
Fibonacci 38.2% 2.98
Last Price 0.13
52-Week Low 0.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar